User talk:Wasitasuksod

Your submission at Articles for creation: Biopharm (September 18)
 Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reasons left by SportingFlyer were:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.


 * If you would like to continue working on the submission, go to Draft:Biopharm and click on the "Edit" tab at the top of the window.
 * If you now believe the draft cannot meet Wikipedia's standards or do not wish to progress it further, you may request deletion. Please go to Draft:Biopharm, click on the "Edit" tab at the top of the window, add "db-self" at the top of the draft text and click the blue "publish changes" button to save this edit.
 * If you need any assistance, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk&action=edit&section=new&nosummary=1&preload=Template:Afc_decline/HD_preload&preloadparams%5B%5D=Draft:Biopharm Articles for creation help desk] or on the [//en.wikipedia.org/w/index.php?title=User_talk:SportingFlyer&action=edit&section=new&nosummary=1&preload=Template:Afc_decline/HD_preload&preloadparams%5B%5D=Draft:Biopharm reviewer's talk page].
 * You can also use Wikipedia's real-time chat help from experienced editors.

SportingFlyer  talk  03:01, 18 September 2018 (UTC)

Your submission at Articles for creation: Biopharm (October 2)
 Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reason left by Dan arndt was:

The comment the reviewer left was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.


 * If you would like to continue working on the submission, go to Draft:Biopharm and click on the "Edit" tab at the top of the window.
 * If you now believe the draft cannot meet Wikipedia's standards or do not wish to progress it further, you may request deletion. Please go to Draft:Biopharm, click on the "Edit" tab at the top of the window, add "db-self" at the top of the draft text and click the blue "publish changes" button to save this edit.
 * If you need any assistance, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk&action=edit&section=new&nosummary=1&preload=Template:Afc_decline/HD_preload&preloadparams%5B%5D=Draft:Biopharm Articles for creation help desk] or on the [//en.wikipedia.org/w/index.php?title=User_talk:Dan_arndt&action=edit&section=new&nosummary=1&preload=Template:Afc_decline/HD_preload&preloadparams%5B%5D=Draft:Biopharm reviewer's talk page].
 * You can also use Wikipedia's real-time chat help from experienced editors.

Dan arndt (talk) 08:23, 2 October 2018 (UTC)

Re: Draft:Biopharm
You (at least I think it might have been you) were asking on the IRC help channel about how many references are needed for an article. It's not really a matter of "number of references". What are needed are a few (3-5 according to some) references that establish the notability of the subject, in this case, according to the criteria that apply to companies. When using non-English sources, it often takes longer for a review because all of our reviewers know English but relatively fewer will know whatever other language the source is in. Additional references can be used to fill in additional details about the company but the notability references are absolutely required. They need to be independent of the subject, in-depth coverage (not simple mentions), and reported by organizations with a reputation for editorial control and fact checking. A great many articles in the business press are also discounted because they consist of reports of routine business transactions that can be found for nearly any company.  — jmcgnh (talk) (contribs) 05:20, 3 October 2018 (UTC)